S'abonner

Tranexamic Acid in Trauma - 20/08/25

Doi : 10.1016/j.annemergmed.2025.03.007 
Whitney J. Barrett a, , Kevin A. Kaucher b, Ross E. Orpet c, Eric M. Campion d, Jeffrey M. Goodloe e, Peter Fischer f, Christopher B. Colwell g, John W. Lyng h
a Department of Emergency Medicine, University of New Mexico School of Medicine, Albuquerque, NM, National Association of EMS Physicians 
b Department of Pharmacy Practice, University of New Mexico Health Sciences Center, Albuquerque, NM, National Association of EMS Physicians 
c Department of Emergency Medicine, First Contact Medical Specialists, Montrose Regional Health, Montrose, CO, National Association of EMS Physicians 
d Department of Surgery, Denver Health Medical Center, Denver, CO, National Association of EMS Physicians 
e Department of Emergency Medicine, University of Oklahoma School of Community Medicine, Tulsa, OK, American College of Emergency Physicians 
f Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, American College of Surgeons Committee on Trauma 
g Department of Emergency Medicine, University of California at San Francisco School of Medicine, San Francisco, CA, National Association of EMS Physicians 
h Department of Emergency Medicine, North Memorial Health Level I Trauma Center, Minneapolis, MN, National Association of EMS Physicians 

Corresponding Author.

Abstract

A Joint Position Statement and Resource Document of NAEMSP, ACEP, and ACS-COT

Prehospital use of tranexamic acid (TXA) has grown substantially over the past decade despite contradictory evidence supporting its widespread use. Since the previous guidance document on the prehospital use of TXA for injured patients was published by the National Association of EMS Physicians, the American College of Surgeons Committee on Trauma, and the American College of Emergency Physicians in 2016, new research has investigated outcomes of patients who receive TXA in the prehospital setting. To provide updated evidence-based guidance on the use of intravenous TXA for injured patients in the emergency medical services (EMS) setting, we performed a structured literature review and developed the following recommendations supported by the evidence summarized in the accompanying resource document.

The National Association of EMS Physicians, the American College of Surgeons Committee on Trauma, and the American College of Emergency Physicians recommends:

Prehospital TXA administration may reduce mortality and improve long-term functional outcomes in adult trauma patients with hemorrhagic shock when administered after lifesaving interventions.
Prehospital TXA administration appears safe, with low risk of thromboembolic events or seizure.
The ideal dose, rate, and route of prehospital administration of TXA for adult trauma patients with hemorrhagic shock has not been determined. Current protocols suggest EMS agencies may administer either a 1-g intravenous (IV) or intraosseous (IO) dose (followed by a hospital-based 1-g infusion over 8 hours), or a 2-g IV or IO dose as an infusion or slow push.
Prehospital TXA administration, if used, for adult trauma patients, should be given to those with clinical signs of hemorrhagic shock and no later than 3 hours postinjury. There is no evidence to date to suggest improved clinical outcomes from TXA initiation beyond this time or in those without clinically significant bleeding.
The role of prehospital TXA in pediatric trauma patients with clinical signs of hemorrhagic shock has not been studied and standardized dosing has not been established. If used, it should be given within 3 hours of injury.
Prehospital TXA administration, if used, should be clearly communicated to receiving health care professionals to promote appropriate monitoring and to avoid duplicate administration(s).
A multidisciplinary team, led by EMS physicians, that includes EMS clinicians, emergency physicians, and trauma surgeons should be responsible for developing a quality improvement program to assess prehospital TXA administration for protocol compliance and identification of clinical complications.

Le texte complet de cet article est disponible en PDF.

Plan


 Funding: This document was developed by NAEMSP, ACEP, and ACS without external funding.
 Contributions: REO, KAK, WJB, CBC developed the plan for literature review and evidence extraction. All authors assume full responsibility for the collection and integrity of the data. REO, KAK, WJB, and EMS participated in the evidence extraction, data analysis, development of the clinical practice guideline. All authors participated in editing. All authors assume full responsibility for the entire content of the manuscript.
 Potential Conflict of Interest:
 External review: This document was created jointly by the National Association of EMS Physicians (NAEMSP), the American College of Surgeons Committee on Trauma (ACS-COT), and the American College of Emergency Physicians (ACEP). It has been independently reviewed and approved by each participating organization (NAEMSP 29 October 2024, ACS-COT 11 October 2024, ACEP 22 January 2025).
 Updating procedure: This document will be reviewed and updated by NAEMSP, ACS-COT, and ACEP 5 years after its publication. At a minimum, the review process should include a search and synthesis of any new and relevant evidence that has been published since the printing of this document.
 This statement is jointly published in Annals of Emergency Medicine, Prehospital Emergency Care, and Journal of Trauma and Acute Care Surgery.


© 2025  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 86 - N° 3

P. e73-e80 - septembre 2025 Retour au numéro
Article précédent Article précédent
  • Regional Anesthesia as a New Required Core Procedure for Emergency Medicine Residents: A Step in the Right Direction
  • Richard J. Gawel, Michael Gottlieb, Michael E. Abboud, Jeffrey A. Kramer, Michael Shalaby
| Article suivant Article suivant
  • Table of Contents

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.